Skip to main content
Premium Trial:

Request an Annual Quote

News Briefs from the Bio-IT World Conference Floor: May 2, 2008

LabVantage and InforSense Partner to Integrate LIMS, Workflow Software
LIMS provider LabVantage Solutions and InforSense have agreed to integrate the InforSense workflow platform with LabVantage's flagship Sapphire LIMS.
LabVantage will also resell the InforSense platform along with Sapphire.
The partners will first focus on integrating the Sapphire BioBanking Solution with the ClinicalSense Module in InforSense.
Ronald Kasner, vice president of corporate development for LabVantage, said that the companies decided to start with the biobanking module because “translational research starts with the specimen,” and the combined solution should offer a “backbone” for researchers working in that area.
He stressed that even though the partners are beginning the integration with those tools, it applies “across the board” for both firms’ products.
Kasner said that LabVantage was looking for a partner to help its customers who needed a way to analyze their data after standardizing it in Sapphire. He said that InforSense made sense because it has a similar modular architecture and also offered customers the ability to plug in third-party analytical tools.
David Menninger, vice president of global marketing and product management at InforSense, said that the partnership will help expand the company’s sales presence.

CLC Bio to Integrate Software with Microsoft Platform
CLC bio is collaborating with Microsoft to integrate its bioinformatics software with Microsoft technologies under the auspices of the Bio-IT Alliance.
So far, CLC bio has added support for Microsoft SQL Server to its database solution, CLC Bioinformatics Database. In addition, its high-performance computing solution, CLC Bioinformatics Cell, supports Microsoft’s high-performance computing solutions, Windows Compute Cluster Server 2003 and Windows HPC Server 2008.
Jan Lomholdt, vice president at CLC bio, told BioInform that the company’s software is also integrated with Microsoft’s Office tools, such as PowerPoint and Excel, and that integration with SharePoint is “in the works.”

Core Informatics Sells LIMS to BioRelix Pharmaceuticals
Core Informatics, a developer of laboratory information management systems, announced that it had installed its Enterprise Core LIMS product to BioRelix Pharmaceuticals.
BioRelix, a drug discovery startup, will use the LIMS to manage all of its drug discovery data.
Core LIMS offers a component-based architecture, which allows customers to choose only those pieces of the system that are required.
"As BioRelix grows and their needs change to require, for example, in-life studies, they can purchase additional components for the Core LIMS to enable that growth," said James Gregory, chief software architect of Core Informatics, in a statement.
Gregory told BioInform at the conference that the company has primarily focused on data management for chemistry, but considers Core LIMS to be applicable to biological data as well.

Exludus, Bioinformatics.Org Partner for Launch of Simpligrid
Exludus, a provider of grid and cluster management software, has partnered with the Bioinformatics Organization to make its newly launched SimpliGrid software available to members of Bioinformatics.Org.
Benoit Marchand, founder and CEO of eXludus, told BioInform that the software allows users to easily build “personal” grids and clusters across a network using a drag-and-drop interface. Researchers can use the tool to distribute bioinformatics processing tasks across multiple computers.
He said that the system also allows users to share interfaces as XML files.
A free trial release candidate version of SimpliGrid is available to members of Bioinformatics.Org through May 31. Participating users will be eligible to purchase a SimpliGrid license at the promotional cost of $99 after the scheduled version 1.0 release on August 15.
Jeff Bizzarro, president of Bioinformatics.Org, said that the software should appeal to life science researchers who “don’t have access to the same kind of hardware that you’d find in a computer science department or even a biotech company.”
Marchand said that the company expects the partnership with Bioinformatics.Org to help educate potential users about the capabilities of the software.

Kirtas, Rescentris Partner to Digitize Archived Text for E-Lab Notebooks
Rescentris and Kirtas Technologies are partnering to use book digitization technology to add archived hardcopy notes and documentation to electronic lab notebooks.
At the conference, the companies were demonstrating how Kirtas’ APT BookScan technology can automatically scan bound texts in order to capture text and images in a searchable format. This data can be included in Rescentris' CERF lab notebook.
Howard Higgins, sales manager for Kirtas, said that the company’s technology can scan 2,400 pages in an hour.
He said the company has primarily worked with large library systems in the past, and recently began targeting the biotech and pharmaceutical market. The firm has installed a system with an undisclosed top-five pharma, he said, and is in negotiations with another.
Customers can either install an APT BookScan in house or use the company’s service offering. 

BioWisdom to Sell OmniViz Software via CambridgeSoft Website
BioWisdom said that it will sell its Omniviz data visualization software to academic researchers through CambridgeSoft’s portal, a partnership that BioWisdom hopes will bring its products to the academic community.
The company this week released version 6 of the OmniViz software, which allows users to identify data columns by attributes and sort them according to those characteristics.

Filed under

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.